Screener
Nurix Therapeutics, Inc. NRIX Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Nurix Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Nurix Therapeutics, Inc.’s 8-K, filed July 9, 2026. Open the filing →
- Filed
- Jul 9, 2026, 4:09 PM EDT
- Accession
- 0001549595-26-000038
FAQ
- What is Nurix Therapeutics, Inc.'s debt-to-equity?
- Nurix Therapeutics, Inc. (NRIX) reported debt-to-equity of 0.1× in Q1 2026.
- How has Nurix Therapeutics, Inc.'s debt-to-equity changed year-over-year?
- Nurix Therapeutics, Inc.'s debt-to-equity increased by 24.5% year-over-year, from 0.1× to 0.1×.
- What is the long-term trend for Nurix Therapeutics, Inc.'s debt-to-equity?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s debt-to-equity has grown at a 16.1% compound annual growth rate (CAGR), from 0× to 0.1×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Nurix Therapeutics, Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude